Literature DB >> 23821023

Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.

Botond K Szabó1, Ariel Saracco, Ervin Tánczos, Peter Aspelin, Karin Leifland, Brigitte Wilczek, Rimma Axelsson.   

Abstract

OBJECTIVES: To correlate contrast-enhanced ultrasound (CEUS) kinetic parameters with traditional and molecular prognostic factors in invasive breast cancer.
METHODS: Seventy-five invasive breast cancers were evaluated with contrast harmonic imaging after the injection of a bolus dose of 2.4 ml sulphur hexafluoride microbubble contrast agent. The lognormal function was used for quantitative analysis of kinetic data. These parameters correlated with traditional prognostic factors (tumour size, histological type, tumour grade, axillary lymph node status) and immunohistochemical biomarkers (ER, PR and HER2 status).
RESULTS: Statistically significant correlation was found between time-to-peak and tumour grade (P value  =  0.023), PR status (P value =  0.042) and axillary node status (P value  =  0.025). Wash-out ratio, measured at 21 s was significantly associated with ER status (P value  =  0.042) and PR status (P value  =  0.026).
CONCLUSIONS: Invasive breast carcinomas exhibiting earlier peak enhancement and faster elimination of microbubble contrast agent at CEUS are found to be associated with established predictors of poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821023     DOI: 10.1007/s00330-013-2960-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Pathophysiologic basis of contrast enhancement in breast tumors.

Authors:  M V Knopp; E Weiss; H P Sinn; J Mattern; H Junkermann; J Radeleff; A Magener; G Brix; S Delorme; I Zuna; G van Kaick
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

4.  Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.

Authors:  Sara Massironi; Dario Conte; Valentina Sciola; Lorena Pirola; Silvia Paggi; Mirella Fraquelli; Clorinda Ciafardini; Matilde P Spampatti; Maddalena Peracchi
Journal:  Dig Liver Dis       Date:  2010-02-20       Impact factor: 4.088

5.  Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.

Authors:  Sejal S Shah; Rhett P Ketterling; Matthew P Goetz; James N Ingle; Carol A Reynolds; Edith A Perez; Beiyun Chen
Journal:  Hum Pathol       Date:  2009-09-16       Impact factor: 3.466

6.  Magnetic resonance imaging of breast cancer and correlation with prognostic factors.

Authors:  Yun-Woo Chang; Kui Hyang Kwon; Deuk Lin Choi; Dong Wha Lee; Min Hyuk Lee; Hye Kyung Lee; Seung Boo Yang; Yongbae Kim; Dae Young Seo
Journal:  Acta Radiol       Date:  2009-11       Impact factor: 1.990

7.  Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor?

Authors:  M D'Onofrio; G A Zamboni; R Malagò; W Mantovani; F Principe; A Gallotti; N Faccioli; M Falconi; P Capelli; R Pozzi Mucelli
Journal:  Ultrasound Med Biol       Date:  2009-10-13       Impact factor: 2.998

8.  Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.

Authors:  C Frouge; J M Guinebretière; G Contesso; R Di Paola; M Bléry
Journal:  Invest Radiol       Date:  1994-12       Impact factor: 6.016

9.  Can contrast-enhanced MR imaging predict survival in breast cancer?

Authors:  B Boné; B K Szabó; L G Perbeck; B Veress; P Aspelin
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

10.  Breast MRI: guidelines from the European Society of Breast Imaging.

Authors:  R M Mann; C K Kuhl; K Kinkel; C Boetes
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

View more
  9 in total

1.  Perfusion contrast-enhanced ultrasound to predict early lymph-node metastasis in breast cancer.

Authors:  Naoko Mori; Shunji Mugikura; Minoru Miyashita; Yumiko Kudo; Mikiko Suzuki; Li Li; Yu Mori; Shoki Takahashi; Kei Takase
Journal:  Jpn J Radiol       Date:  2018-11-20       Impact factor: 2.374

2.  Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.

Authors:  Yong-Mei Wang; Wei Fan; Kai Zhang; Li Zhang; Zhen Tan; Rong Ma
Journal:  Br J Radiol       Date:  2016-05-04       Impact factor: 3.039

3.  Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer.

Authors:  Irene Vraka; Evangelia Panourgias; Emmanouil Sifakis; Andreas Koureas; Petros Galanis; Dionysios Dellaportas; Athanasios Gouliamos; Aristides Antoniou
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

4.  Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.

Authors:  Yi Liu; Hua Liu; Chang-Lin Qian; Mei-Sui Lin; Feng-Hua Li
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

5.  Diagnostic and prognostic values of contrast‑enhanced ultrasound combined with diffusion‑weighted magnetic resonance imaging in different subtypes of breast cancer.

Authors:  Gui-Feng Liu; Zong-Qiang Wang; Shu-Hua Zhang; Xue-Feng Li; Lin Liu; Ying-Ying Miao; Shao-Nan Yu
Journal:  Int J Mol Med       Date:  2018-03-27       Impact factor: 4.101

6.  Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.

Authors:  Eva Janu; Lucie Krikavova; Jirina Little; Karel Dvorak; Dagmar Brancikova; Eva Jandakova; Tomas Pavlik; Petra Kovalcikova; Tomas Kazda; Vlastimil Valek
Journal:  BMC Med Imaging       Date:  2020-06-17       Impact factor: 1.930

7.  Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer.

Authors:  Anne Rix; Marion Piepenbrock; Barbara Flege; Saskia von Stillfried; Patrick Koczera; Tatjana Opacic; Nina Simons; Peter Boor; Sven Thoröe-Boveleth; Roel Deckers; Jan-Niklas May; Twan Lammers; Georg Schmitz; Elmar Stickeler; Fabian Kiessling
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

8.  Differentiation Between Granulomatous Lobular Mastitis and Breast Cancer Using Quantitative Parameters on Contrast-Enhanced Ultrasound.

Authors:  Liang Yin; Enock Adjei Agyekum; Qing Zhang; Lei Pan; Ting Wu; Xiudi Xiao; Xiao-Qin Qian
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

9.  Contrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic Factors.

Authors:  Li-Xia Zhao; Hui Liu; Qing Wei; Guang Xu; Jian Wu; Hui-Xiong Xu; Rong Wu; Huan Pu
Journal:  Biomed Res Int       Date:  2015-12-31       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.